Briacell Therapeutics Corp
TSX:BCT
तय करें कि किस कीमत पर खरीदना आपके लिए उचित होगा। तैयार रहने में हम आपकी मदद करेंगे।
|
B
|
Briacell Therapeutics Corp
TSX:BCT
|
CA |
|
B
|
Boston Beer Company Inc
F:BBEA
|
US |
|
C
|
Callaway Golf Co
F:CLY
|
US |
|
L
|
Lytix Biopharma AS
F:6BG
|
NO |
|
M
|
Merck & Co Inc
F:6MK
|
US |
|
B
|
Bristol-Myers Squibb Co
F:BRM
|
US |
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
L
|
Louisiana-Pacific Corp
F:LP3
|
US |
|
C
|
CITIC Ltd
XMUN:CPF
|
CN |
|
Recharge Metals Ltd
ASX:REC
|
AU |
|
Golden Agri-Resources Ltd
F:4G3
|
SG |
|
Asia Energy Logistics Group Ltd
F:EJ1C
|
HK |
|
Norsk Hydro ASA
F:NOHA
|
NO |
|
G
|
Grupo Aeroportuario del Sureste SAB de CV
SWB:AEDA
|
MX |
|
I
|
IAMGOLD Corp
XMUN:IAL
|
CA |
|
Opendoor Technologies Inc
NASDAQ:OPEN
|
US |
|
Suncorp Group Ltd
ASX:SUN
|
AU |
|
F
|
Fortis Inc
F:12F
|
CA |
|
G
|
Gartner Inc
XMUN:GGRA
|
US |
|
S
|
Siemens AG
XMUN:SIE
|
DE |
|
W
|
Weatherford International PLC
F:0WE
|
US |
|
S
|
Sanmina Corp
XMUN:SAYN
|
US |
आंतरिक मूल्य
Briacell Therapeutics Corp का आंतरिक मूल्य भरोसेमंद ढंग से निकालने के लिए पर्याप्त डेटा नहीं है।
क्या हमारे मूल्यांकन वास्तव में कारगर हैं? बैकटेस्ट के परिणाम देखें .
मौलिक विश्लेषण
Briacell Therapeutics क्या करती है
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The firm is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer.
- मुख्यालय
- कनाडा CA
- कर्मचारी
- 16
- IPO की तारीख
- अक्टू. 12, 2006
